Cargando…

Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue

BACKGROUND: Nonsteroidal anti-inflammatory drugs are contraindicated in the third trimester of pregnancy due to negative effects including alteration of uteroplacental blood flow, premature ductus arteriosus closure, and adverse effects on the fetal kidney. However, many women are unaware of these r...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Hayley R., Lai, Dickson, Kim, Hugh, Wright, Tricia E., Coughtrie, Michael W.H., Collier, Abby C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548959/
https://www.ncbi.nlm.nih.gov/pubmed/33072523
http://dx.doi.org/10.1016/j.toxrep.2020.09.003
_version_ 1783592718944960512
author Price, Hayley R.
Lai, Dickson
Kim, Hugh
Wright, Tricia E.
Coughtrie, Michael W.H.
Collier, Abby C.
author_facet Price, Hayley R.
Lai, Dickson
Kim, Hugh
Wright, Tricia E.
Coughtrie, Michael W.H.
Collier, Abby C.
author_sort Price, Hayley R.
collection PubMed
description BACKGROUND: Nonsteroidal anti-inflammatory drugs are contraindicated in the third trimester of pregnancy due to negative effects including alteration of uteroplacental blood flow, premature ductus arteriosus closure, and adverse effects on the fetal kidney. However, many women are unaware of these risks, and commonly report their use in pregnancy. We aimed to determine if umbilical cord was a reliable matrix for detecting NSAID use, determine incidence of use close to labour, and uncover associations with obstetric/neonatal outcomes. METHODS: We developed a UHPLC-MS/MS method to simultaneously detect diclofenac, ibuprofen, indomethacin, naproxen, and salicylic acid in plasma and umbilical cord lysate. Using this method, we screened 380 lysates to determine the prevalence of NSAID use. Results were compared to the clinical outcomes in pregnancy using ICD9/10 chart codes (n = 21). RESULTS: The UHPLC-MS/MS method has excellent linearity, accuracy, and precision in solvent and plasma, but lower sensitivity in umbilical cord lysate. We report a 3 % rate of NSAID ingestion within days of labour – the pharmacokinetically-determined window for active ingestion. There were no significant differences observed for maternal, obstetric, or neonatal outcomes between the NSAID positive group (n = 11) and NSAID negative group (n = 369). CONCLUSIONS: Because NSAID use in third trimester is contraindicated, even a 3% usage rate is alarmingly high. Based on UHPLC-MS/MS performance of umbilical cord lysate, 3% is likely a conservative estimate. Recent adoption of NSAIDs under clinical supervision to support in vitro fertilisation and prevent pre-eclampsia indicates future work should focus on determining safe dosages of NSAIDs and the correct therapeutic window in pregnancy.
format Online
Article
Text
id pubmed-7548959
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75489592020-10-16 Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue Price, Hayley R. Lai, Dickson Kim, Hugh Wright, Tricia E. Coughtrie, Michael W.H. Collier, Abby C. Toxicol Rep Regular Article BACKGROUND: Nonsteroidal anti-inflammatory drugs are contraindicated in the third trimester of pregnancy due to negative effects including alteration of uteroplacental blood flow, premature ductus arteriosus closure, and adverse effects on the fetal kidney. However, many women are unaware of these risks, and commonly report their use in pregnancy. We aimed to determine if umbilical cord was a reliable matrix for detecting NSAID use, determine incidence of use close to labour, and uncover associations with obstetric/neonatal outcomes. METHODS: We developed a UHPLC-MS/MS method to simultaneously detect diclofenac, ibuprofen, indomethacin, naproxen, and salicylic acid in plasma and umbilical cord lysate. Using this method, we screened 380 lysates to determine the prevalence of NSAID use. Results were compared to the clinical outcomes in pregnancy using ICD9/10 chart codes (n = 21). RESULTS: The UHPLC-MS/MS method has excellent linearity, accuracy, and precision in solvent and plasma, but lower sensitivity in umbilical cord lysate. We report a 3 % rate of NSAID ingestion within days of labour – the pharmacokinetically-determined window for active ingestion. There were no significant differences observed for maternal, obstetric, or neonatal outcomes between the NSAID positive group (n = 11) and NSAID negative group (n = 369). CONCLUSIONS: Because NSAID use in third trimester is contraindicated, even a 3% usage rate is alarmingly high. Based on UHPLC-MS/MS performance of umbilical cord lysate, 3% is likely a conservative estimate. Recent adoption of NSAIDs under clinical supervision to support in vitro fertilisation and prevent pre-eclampsia indicates future work should focus on determining safe dosages of NSAIDs and the correct therapeutic window in pregnancy. Elsevier 2020-09-08 /pmc/articles/PMC7548959/ /pubmed/33072523 http://dx.doi.org/10.1016/j.toxrep.2020.09.003 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Price, Hayley R.
Lai, Dickson
Kim, Hugh
Wright, Tricia E.
Coughtrie, Michael W.H.
Collier, Abby C.
Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue
title Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue
title_full Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue
title_fullStr Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue
title_full_unstemmed Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue
title_short Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue
title_sort detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548959/
https://www.ncbi.nlm.nih.gov/pubmed/33072523
http://dx.doi.org/10.1016/j.toxrep.2020.09.003
work_keys_str_mv AT pricehayleyr detectionandquantitationofnonsteroidalantiinflammatorydruguseclosetothetimeofbirthusingumbilicalcordtissue
AT laidickson detectionandquantitationofnonsteroidalantiinflammatorydruguseclosetothetimeofbirthusingumbilicalcordtissue
AT kimhugh detectionandquantitationofnonsteroidalantiinflammatorydruguseclosetothetimeofbirthusingumbilicalcordtissue
AT wrighttriciae detectionandquantitationofnonsteroidalantiinflammatorydruguseclosetothetimeofbirthusingumbilicalcordtissue
AT coughtriemichaelwh detectionandquantitationofnonsteroidalantiinflammatorydruguseclosetothetimeofbirthusingumbilicalcordtissue
AT collierabbyc detectionandquantitationofnonsteroidalantiinflammatorydruguseclosetothetimeofbirthusingumbilicalcordtissue